v3.26.1
REVERSE MERGER (Details Narrative) - USD ($)
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Feb. 17, 2026
Business Combination [Line Items]        
Shares issued   51,203    
Common stock, par value $ 0.0001   $ 0.0001  
Preferred stock, par value $ 0.000001   $ 0.000001  
Impairment of long-lived assets $ 13,337      
Gain on disposal of subsidiary $ 7,310,719      
Unwind Agreement [Member]        
Business Combination [Line Items]        
Debt securities current       $ 300,000
Debt securities non current       $ 10,000
Phytanix Bio Inc [Member]        
Business Combination [Line Items]        
Outstanding capital stock of Phytanix Bio.       100.00%
Phytanix Bio Inc [Member] | Series C Preferred Stock [Member]        
Business Combination [Line Items]        
Shares issued 5,705      
Preferred stock, par value $ 0.000001      
Phytanix Bio Inc [Member] | Series C-1 Preferred Stock [Member]        
Business Combination [Line Items]        
Shares issued 950,000      
Preferred stock, par value $ 0.000001      
Phytanix Bio Inc [Member] | Series D Preferred Stock [Member]        
Business Combination [Line Items]        
Shares issued 20,000      
Preferred stock, par value $ 0.000001      
Warrants purchased 715,493      
Common Stock [Member]        
Business Combination [Line Items]        
Shares issued   51,203    
Common Stock [Member] | Phytanix Bio Inc [Member]        
Business Combination [Line Items]        
Shares issued 117,690      
Common stock, par value $ 0.0001      
Equity interests in acquiree, percentage 19.99%